[go: up one dir, main page]

DE69831594D1 - Intakte oder zerstörte insektenzellen als antigenadjuvant - Google Patents

Intakte oder zerstörte insektenzellen als antigenadjuvant

Info

Publication number
DE69831594D1
DE69831594D1 DE69831594T DE69831594T DE69831594D1 DE 69831594 D1 DE69831594 D1 DE 69831594D1 DE 69831594 T DE69831594 T DE 69831594T DE 69831594 T DE69831594 T DE 69831594T DE 69831594 D1 DE69831594 D1 DE 69831594D1
Authority
DE
Germany
Prior art keywords
insect cells
adjuvant
antigen
antigenadjuvant
intact
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69831594T
Other languages
English (en)
Other versions
DE69831594T2 (de
Inventor
Eugene Smith
James Debartolomeis
Igorevitch Voznesenski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merial LLC
Original Assignee
Protein Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25510359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69831594(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Protein Sciences Corp filed Critical Protein Sciences Corp
Publication of DE69831594D1 publication Critical patent/DE69831594D1/de
Application granted granted Critical
Publication of DE69831594T2 publication Critical patent/DE69831594T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69831594T 1997-11-07 1998-11-04 Intakte oder zerstörte insektenzellen als antigenadjuvant Expired - Lifetime DE69831594T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/965,698 US6224882B1 (en) 1997-11-07 1997-11-07 Insect cells or fractions as adjuvant for antigens
US965698 1997-11-07
PCT/US1998/023472 WO1999024049A1 (en) 1997-11-07 1998-11-04 Insect cells or fractions as adjuvant for antigens

Publications (2)

Publication Number Publication Date
DE69831594D1 true DE69831594D1 (de) 2006-01-26
DE69831594T2 DE69831594T2 (de) 2006-07-06

Family

ID=25510359

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69831594T Expired - Lifetime DE69831594T2 (de) 1997-11-07 1998-11-04 Intakte oder zerstörte insektenzellen als antigenadjuvant

Country Status (11)

Country Link
US (1) US6224882B1 (de)
EP (2) EP1033995B1 (de)
AT (1) ATE304369T1 (de)
AU (1) AU1379599A (de)
CA (1) CA2309003C (de)
DE (1) DE69831594T2 (de)
DK (1) DK1033995T3 (de)
ES (1) ES2248921T3 (de)
NZ (1) NZ504424A (de)
PT (1) PT1033995E (de)
WO (1) WO1999024049A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
US6342216B1 (en) * 1999-03-17 2002-01-29 The Board Of Regents, The University Of Texas System Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
AUPQ233799A0 (en) 1999-08-19 1999-09-09 Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales Recombinant sub-unit vaccine
CA2414207A1 (en) * 2000-05-31 2001-12-06 Isaiah J. Fidler Adjuvant preparation for the induction of specific immunity
US20060228326A1 (en) * 2002-10-22 2006-10-12 Fidler Isaiah J Active specific immunotherapy of cancer metastasis
EP1606419A1 (de) 2003-03-18 2005-12-21 Quantum Genetics Ireland Limited Systeme und methoden zur erhohung der milchproduktion in tieren
US7468273B2 (en) 2003-05-01 2008-12-23 Meial Limited Canine GHRH gene, polypeptides and methods of use
WO2005021713A2 (en) 2003-06-20 2005-03-10 Protein Sciences Corporation Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
US8992939B2 (en) 2003-07-11 2015-03-31 Novavax, Inc. Highly efficient influenza matrix (M1) proteins
US8506967B2 (en) 2003-07-11 2013-08-13 Novavax, Inc. Functional influenza virus like particles (VLPs)
US8080255B2 (en) * 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
MXPA06005424A (es) 2003-11-13 2007-01-25 Univ Georgia Res Found Metodos para caracterizar virus de enfermedad bursal infecciosa.
JP2007525217A (ja) 2004-02-19 2007-09-06 ザ ガバナーズ オブ ザ ユニバーシティー オブ アルバータ レプチンプロモーター多型及びその使用
PT1881845E (pt) 2005-04-25 2010-05-31 Merial Ltd Vacinas de vírus nipah
US20080241184A1 (en) 2005-08-25 2008-10-02 Jules Maarten Minke Canine influenza vaccines
CA2621666A1 (en) * 2005-09-09 2007-03-15 Universitaet Zuerich Antigens for vaccination against and detection of mycoplasma suis
US7771995B2 (en) 2005-11-14 2010-08-10 Merial Limited Plasmid encoding human BMP-7
EP1951751B1 (de) 2005-11-14 2017-11-01 Merial, Inc. Gentherapie bei nierenversagen
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
WO2008009115A1 (en) * 2006-07-18 2008-01-24 Ottawa Health Research Institute Disparate suicide carrier cells for tumor targeting of promiscuous oncolytic viruses
EP3168307B1 (de) 2008-11-28 2020-07-15 Boehringer Ingelheim Animal Health USA Inc. Rekombinanter impfstoff gegen vogelgrippe und verwendungen davon
CN103585643A (zh) 2009-04-03 2014-02-19 梅里亚有限公司 运载新城疫病毒的禽疫苗
JP5913316B2 (ja) 2010-08-31 2016-04-27 メリアル リミテッド ニューカッスル病ウイルスをベクターとするヘルペスウイルスワクチン
WO2012090073A2 (en) 2010-12-30 2012-07-05 The Netherlands Cancer Institute Methods and compositions for predicting chemotherapy sensitivity
EP2694678A2 (de) 2011-04-04 2014-02-12 Netherland Cancer Institute Verfahren und zusammensetzungen zur vorhersage der resistenz gegenüber einer antikrebsbehandlung
US20140296248A1 (en) 2011-04-04 2014-10-02 Stichting het Nederlands Kanker Instiuut-Antoni van Leeuwenhoek ziekenhuis Methods and compositions for predicting resistance to anticancer treatment
AU2012245395A1 (en) 2011-04-20 2013-11-14 Merial, Inc. Adjuvanted rabies vaccine with improved viscosity profile
JP6407714B2 (ja) 2011-04-25 2018-10-17 アドヴァンスド バイオサイエンス ラボラトリーズ インコーポレイテッド 短縮型ｈｉｖエンベロープタンパク質（ｅｎｖ）、前記に関連する方法及び組成物
WO2012166493A1 (en) 2011-06-01 2012-12-06 Merial Limited Needle-free administration of prrsv vaccines
ES2626297T3 (es) 2011-08-12 2017-07-24 Merial, Inc. Preservación asistida por vacío de productos biológicos, en particular de vacunas
WO2013093629A2 (en) 2011-12-20 2013-06-27 Netherlands Cancer Institute Modular vaccines, methods and compositions related thereto
WO2013138776A1 (en) 2012-03-16 2013-09-19 Merial Limited Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
WO2014164697A1 (en) 2013-03-12 2014-10-09 Merial Limited Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof
PL2994162T3 (pl) 2013-05-08 2021-10-18 Pharmgate Biologics Inc. Szczepionka przeciwko pcv2 i mykoplazmie
WO2016073410A1 (en) 2014-11-03 2016-05-12 Merial, Inc. Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
CA2990643C (en) 2015-06-23 2023-10-17 Merial, Inc. Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
CN108135997A (zh) 2015-08-20 2018-06-08 梅里亚股份有限公司 Fcv重组疫苗及其用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK590288D0 (da) 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US5174993A (en) 1981-12-24 1992-12-29 Health Research Inc. Recombinant avipox virus and immunological use thereof
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5338683A (en) 1981-12-24 1994-08-16 Health Research Incorporated Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
US5833975A (en) 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US5019384A (en) 1986-06-30 1991-05-28 Massachusetts Institute Of Technology Immunonodulating compositions and their use
IE872748L (en) 1986-10-16 1988-04-16 Arjomari Europ Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
CA2003300A1 (en) 1988-11-21 1990-05-21 Franklin Volvovitz Skin test and test kit for aids
WO1991009870A1 (de) 1989-12-22 1991-07-11 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive proteine von borrelia burgdorferi, zusammenhängende testkits und impfstoff
US5514375A (en) 1990-08-15 1996-05-07 Virogenetics Corporation Flavivirus recombinant poxvirus vaccine
MY109299A (en) 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
US5503834A (en) 1990-11-20 1996-04-02 Virogenetics Corporation Measles virus recombinant poxvirus vaccine
CA2104014C (en) 1991-02-15 2000-05-02 David E. Briles Structural gene of pneumococcal protein
US5766597A (en) 1991-03-07 1998-06-16 Virogenetics Corporation Malaria recombinant poxviruses
DE69233158T2 (de) 1991-03-07 2004-05-13 Connaught Technology Corp., Greenville Gentechnologisch hergestellter stamm für impfstoffe
JP3504659B2 (ja) 1991-06-14 2004-03-08 ヴァイロジェネティクス コーポレイション 免疫不全ウイルス組換えポックスウイルスワクチン
EP0597016A4 (en) 1991-07-26 1996-04-24 Virogenetics Corp Infectious bursal disease virus recombinant poxvirus vaccine.
WO1993004175A1 (en) 1991-08-15 1993-03-04 Smithkline Beecham Biologicals (S.A.) Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines
JPH06511154A (ja) 1991-10-18 1994-12-15 コノート　ラボラトリーズ　インコーポレイテッド 組換えＢｏｒｒｅｌｉａタンパクの製造法
EP0650527B1 (de) 1991-10-22 2003-03-12 Symbicom Ab Verbesserungen der diagnose und der prophylaxe von borrelia burgdorferi
JPH06166635A (ja) * 1992-06-18 1994-06-14 San Five Kk 免疫アジュバント
US5529780A (en) 1994-03-30 1996-06-25 Virogenetics Corporation Nucleotide and amino acid sequences of canine herpesvirus gB and gC
US5528771A (en) 1994-07-29 1996-06-25 Yudin; Beniamin Back support
AU711183B2 (en) 1994-08-19 1999-10-07 Biotransplant Incorporated Genetically engineered swine cells
JP4922923B2 (ja) 2004-04-13 2012-04-25 ドナルドソン カンパニー，インコーポレイティド 液体ろ過用のフィルタ・カートリッジ
CN116285747A (zh) 2014-03-21 2023-06-23 艾利丹尼森公司 无面标签以及相关系统和方法

Also Published As

Publication number Publication date
PT1033995E (pt) 2005-11-30
WO1999024049A1 (en) 1999-05-20
CA2309003A1 (en) 1999-05-20
US6224882B1 (en) 2001-05-01
NZ504424A (en) 2001-09-28
ATE304369T1 (de) 2005-09-15
WO1999024049A9 (en) 1999-08-12
EP1611897A2 (de) 2006-01-04
DK1033995T3 (da) 2006-01-30
EP1033995A4 (de) 2001-01-10
DE69831594T2 (de) 2006-07-06
AU1379599A (en) 1999-05-31
EP1033995B1 (de) 2005-09-14
EP1611897A3 (de) 2007-08-15
ES2248921T3 (es) 2006-03-16
EP1033995A1 (de) 2000-09-13
CA2309003C (en) 2012-10-02

Similar Documents

Publication Publication Date Title
DE69831594D1 (de) Intakte oder zerstörte insektenzellen als antigenadjuvant
BR9708387A (pt) Processo para vacinação de um mamìfero a um antìgeno selecionado, células patogênica e hospedeira, composição de vacina, ácido nucleico, e, opsonina engenheirada.
ATE229978T1 (de) Helicobacter proteine und impstoffe
ATE295895T1 (de) Genetischer impfstoff gegen den immunschwäche virus
DE59010913D1 (de) Toxoplasma gondii-Antigene, ihre Herstellung und ihre Verwendung
ATE90388T1 (de) Schuetzendes peptid-antigen.
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
DK0586076T3 (da) Rekombinant adenovirus-vacciner
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
ATE241385T1 (de) Rekombinante adenovirus-vakzinen
AU4803785A (en) Cross-reactive and protective epitopes of circumsporozoite proteins
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
SE8700466D0 (sv) Vaccines against melanoma
WO2002000250A3 (en) Hiv-1 vaccines and screening methods therefor
Adreeva et al. On the possibility of using burnt ceramic masses for making up for damaged ceramics

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERIAL LTD., HARLOW, ESSEX, GB

8327 Change in the person/name/address of the patent owner

Owner name: MERIAL LTD., DULUTH, GA., US

8310 Action for declaration of annulment
8313 Request for invalidation rejected/withdrawn